SUBSCRIBERS
China Inc on buying spree of global healthcare assets
Surge driven by firms seeking to diversify, with slowing local growth, govt push to upgrade 'Made in China' brand
Add BT as a preferred sourcePublished Wed, Jul 6, 2016 · 09:50 PM
Beijing
CHINA'S healthcare companies are on an acquisition tear, attempting to buy their way into international markets like never before.
Chinese firms have announced more than US$3.9 billion in overseas acquisitions in the pharmaceutical, biotechnology and healthcare sectors this year - a pace on track to exceed last year's record total and a tenfold increase from the amount spent in all of 2012, data compiled by Bloomberg shows.
Share with us your feedback on BT's products and services
